Teaching Healing Searching Serving
College of Pharmacy
Dean's Message
About the College
   
Current Students
Prospective Students
Alumni & Friends
Experiential Education
Faculty
   Faculty Development
  Faculty Resources
  Administration and Staff
  Alphabetical
  By Department
  COP Web Server
  E-Learning Guides
Staff
For Pharmacists
Degree Programs
Departments
  Pharmaceutical Sciences
     ·   Division of Radiation Health
  Pharmacy Practice
     ·   Division PEP
Programs
Parents Club
Pharmacy Camp
PCAT Prep
Summer Program
COP Home
UAMS



Administrative Leadership Opportunity

 

Pharmaceutical Sciences Faculty Member

Born

Cherng-ju Kim, Ph.D.
Professor
Department of Pharmaceutical Sciences
Phone: 501-686-5090
Fax: 501-526-6510
Office: Education II Building, 6/110C
Email:ckim@uams.edu

Education
B.S., 1974; Chemical Engineering, Korea University, Seoul, Korea
M.E. (Environmental), 1979; Environmental Science and Engineering, Manhattan College, Riverdale, New York
Ph.D., 1984; Chemical Engineering, McMaster University, Hamilton, Ontario, Canada
(Polymer Reaction Engineering)

Teaching Responsibilities
Pharmaceutics

Research Interests
Dr. Kim’s primary research interests include the development of polymeric materials for controlled release drug delivery systems and the modulation of drug release kinetics.  Surface area modulated systems have been extensively developed to overcome a limitation of common

 

 

 

 

 

 

 

 

 

 

 

dosage form geometry.  To minimize and eliminate the effect of drug diffusion from matrix controlled systems, a change of drug moiety has been evaluated for linear extended release.  A new process to produce biodegradable micro-particles for the delivery of peptides is under development and its operating variables are investigated for a large scale production.  Non-matrix controlled transdermal delivery systems are investigated using sol-gel and thermal gelation processes.  His innovative controlled release technologies at Temple University and UAMS eventually led to fruitful results and reached a major licensing agreement with a pharmaceutical company (the largest licensing agreement in Temple University technology transfer history at that time) and a foreign pharmaceutical company, respectively.